ROCKET PHARMACEUTICALS, INC.
Company Stats
- Market Cap
- $288.7M
- as of Sep 30, 2026
- Shares Outstanding
- 109.8M
- Free Float
- 78.4%
Income Statement
- Revenue
- $0
- Operating Income
- -$231.7M
- Net Income
- -$223.1M
- EBITDA
- -$222.8M
Cash Flow
- Free Cash Flow
- -$190.5M
- FCF Yield
- -66.0%
- Owner FCF Yield
- -78.8%
Balance Sheet
- Cash & Equivalents
- $77.6M
Returns & Capital
- SBC, 3Y Avg
- $40.1M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $0 | -$190.5M | — |
| FY2024 | $0 | -$215.6M | — |
| FY2023 | $0 | -$211.4M | — |
| FY2022 | $0 | -$186.5M | — |
| FY2021 | $0 | -$128.8M | — |
Annual filing data through FY ended December 31, 2025; shares and float as of October 28, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges
Healthcare Earnings: Demand Surges, Costs Bite Back